MarketWatch Automation
Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.98% plunged 13.49% to $265.33 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.31% rising 0.93% to 15,225.15 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.41% rising 1.87% to 35,227.03. Moderna Inc. closed $232.16 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.75% rose 2.10% to $121.35, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +2.11% rose 3.14% to $208.79, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.97% rose 2.18% to $55.41. Trading volume (19.7 M) eclipsed its 50-day average volume of 13.3 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.














